Phase IV study of safety and efficacy of docetaxel in combination with prednisone in advanced hormone refractory prostate cancer treatment
Phase of Trial: Phase IV
Latest Information Update: 27 May 2011
At a glance
- Drugs Docetaxel; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 27 May 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2005-001873-91).
- 21 Apr 2008 The expected completion date for this trial is now 1 Oct 2007.